Moderated by:

Gorav Ailawadi, University of Michigan
Tsuyoshi Kaneko, Washington University St. Louis

Implications of 5-year Partner and 4-year Evolut Low-risk Trial Data

Vinod Thourani, Piedmont Heart Institute

Durability of TAVR in Young Patients

Kendra Grubb, Emory University

Decision Making in Low-risk Patients with AS

Ibrahim Sultan, University of Pittsburgh

Panel Discussion with Q&A

All faculty

Recorded on April 3, 2024